Overview

Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for the narcotic analgesic, morphine, post surgery
Phase:
Phase 3
Details
Lead Sponsor:
Cumberland Pharmaceuticals
Treatments:
Ibuprofen